Reckitt Benckiser Group PLC Director Declaration

RNS Number : 5441I

Reckitt Benckiser Group PLC

27 March 2024

 

27 March 2024

 

RECKITT BENCKISER GROUP PLC

 

Director Declaration

 

Reckitt Benckiser Group plc ('Reckitt') announces that Elane Stock, a Non-Executive Director of Reckitt, has been appointed as a Director on the Board of Fomento Económico Mexicano, S.A.B. de C.V. (FEMSA) (NYSE: FMX; BMV: FEMSA UBD, FEMSA BD) effective 22 March 2024.

 

This notification is made in accordance with Listing Rule 9.6.14 of the FCA's Listing Rules.

 

CONTACT DETAILS:

 

Contacts

 

Richard Joyce                                                              [phone]

Investor Relations

 

Catheryn O'Rourke                                                       [phone]

General Counsel & Company Secretary

 

 

About Reckitt:

 

Reckitt* exists to protect, heal and nurture in the relentless pursuit of a cleaner, healthier world. We believe that access to the highest-quality hygiene, wellness and nourishment is a right, not a privilege.

 

Reckitt is the company behind some of the world's most recognisable and trusted consumer brands in hygiene, health and nutrition, including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, Woolite and more.

 

Every day, more than 20 million Reckitt products are bought globally. We always put consumers and people first, seek out new opportunities, strive for excellence in all that we do and build shared success with all our partners. We aim to do the right thing, always.

 

We are a diverse global team of c. 40,000 colleagues. We draw on our collective energy to meet our ambitions of purpose-led brands, a healthier planet and a fairer society.  Find out more, or get in touch with us at www.reckitt.com

 

* Reckitt is the trading name of the Reckitt Benckiser group of companies

 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

RDNJRMTTMTMTBFI